Scholarly Index
Karl Walravens
GlaxoSmithKline (Belgium); 2,811 total citations; 69 total publications; best world rank #646
GlaxoSmithKline (Belgium)
2,811Total citations
69Total publications
26H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Brucella: diagnosis, epidemiology, treatment | Lifetime | 646 | BE 12 | 86.99 |
| Burkholderia infections and melioidosis | Lifetime | 930 | BE 12 | 66.98 |